World Pharma News - Trasylol® - One Thousand Lives A Month

Home News Channels Contact Us Search XING Forums Members Login

Conferences & Events BioQatar Symposium 2008 - Translating Clinical Research into Business Ventures Clinical Development in the Nordic Region & Northern Europe 4th Modern Drug Discovery and Development Summit Forecasting for Pharma by Jacob Fleming Conferences	Research & Development ERS COPD Research Award 2008 sponsored by Boehringer Ingelheim Philips develops ultrasound-activated microbubbles for localized delivery of cancer drugs Pharmaceutical Forum Concluded Successfully FDA Analysis on Cholesterol Lowering Medications
Read more...	Read more...

Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free service delivered by FeedBurner).

Non progredi est regredi.

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Pharmaceutical RSS News

Start your day with worldwide pharmaceutical

European Commission - Pharmaceuticals
FDA

US Food and Drug Administration

Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.

Email:

World Pharma News .net / Published News

Our RSS News Channels

Sponsored Ads

Trasylol® - One Thousand Lives A Month

Monday, 18 February 2008

A renowned researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago. Scott Pelley reports.
CBSNews.com

Sponsored Ads

Product European Medicines Agency recommends update of product information of Tysabri FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial New low-dose oral contraceptive YAZ® launched in Europe Novo Nordisk launches a next generation of FlexPen®	Clinical Trials Bayer Reports Progress in Clinical Program for Riociguat Data from one-year liraglutide phase 3 study published in The Lancet TRANSCEND® trial confirms long-term protective benefits and excellent tolerability profile Anavex completes successful preclinical studies on lead Alzheimer's drug candidate Rivaroxaban Phase II Data in ACS to be Presented at AHA Congress in November	Corporate Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme Shire Limited has changed its name to Shire plc Bayer starts new research cooperation in Asia US Court Denies Teva's Motion For Summary Judgment In Pulmicort Respules Patent Litigation Nycomed optimises its European manufacturing network	Financial Novo Nordisk and Innate Pharma swap product rights Roche invests 215 million Swiss francs in diagnostics facility at Penzberg Novo Nordisk acquires intellectual property rights from Neose Technologies Bayer HealthCare acquires German DIREVO Biotech AG Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
Read more...	Read more...	Read more...	Read more...

Conferences & Events

Research & Development

Welcome

Pharmaceutical Companies

Sponsored Ads

Pharmaceutical RSS News

World Pharma News .net / Published News

Our RSS News Channels

Sponsored Ads

Most Read - Product

Sponsored Ads

Product

Clinical Trials

Corporate

Financial